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ievice Interactions
nd Cardiomyopathy
e read with much interest the Research Correspondence by
ehta et al. (1) of 2 cases of device interactions in patients with
dvanced cardiomyopathy. We experienced the same problem with
patient equipped with a St. Jude Medical (SJM) implantable
ardioverter-defibrillator (Atlas II  HF, model V-367, St. Jude
edical, Sunnyvale, California) who was implanted with a Heart-
ate II left ventricular assist device (LVAD) (Thoratec Heartmate
I, Thoratec, Pleasanton, California). Similar to the 2 cases
eported by the group of Mehta et al. (1), our case demonstrated no
ossible telemetry after the implantation of the LVAD pump, and
he replacement of the implantable cardioverter-defibrillator
ICD) was the only clinical solution. Mehta et al. (1) partially
larified the nature of the interaction. We also found that it was
pecifically produced by the Heartmate II pulse-width modulator,
hich operates at a constant frequency of 7.2 kHz. However, in
ur case, the patient was implanted with a new generation of SJM
RT-D (which uses an operating frequency of 64 kHz). Accord-
ng to the explanation given in the correspondence from Mehta et
l. (1), no interaction would have been expected. In fact, the
ederal Communications Commission who regulates the operat-
ng frequencies of all implantable devices has mandated device
perating in UHF bands to use a “listen-before-talking” (LBT)
ccessing protocol for safety reasons (2). All ICDs, even the last
urrent and Promote generation from SJM, use an LBT assessing
rotocol operating at a frequency of 8 kHz (communication from SJM
elgium, St. Jude Medical, Zaventem, Belgium, April 2008) (Table 1).
nteractions could thus occur either between the pulse-width
odulator and the LBT protocol (newest generation) and/or the
ata transmission per se (oldest generation). This was clearly
emonstrated by clinical tests that we performed with demonstra-
ion devices: the initial interrogation of all SJM ICDs is always
mpossible if the distance between the ICD and the LVAD pump
s shorter than 6 inches. However, the communication to the
evice is possible close to the Heartmate for the newest generation
f SJM ICDs (LBT: 8 kHz; operating frequency: 64 kHz) if the
nitial recognition of the ICD is established far away from the
VAD pump. By contrast, with the oldest generation of SJM
BT, Operating, and Wireless Frequencies Used by Differentenerations of SJM Implantable Cardioverter-Defibrillator
Table 1
LBT, Operating, and Wireless Frequencies Used by Different
Generations of SJM Implantable Cardioverter-Defibrillator
LBT,
kHz
Operating
Frequency,
kHz
Wireless Telemetry
(MICS Band),
MHz
SJM Promote (model RF-3213) 8 64 402–405
SJM Atlas II (model V-367) 8 64 N/A
SJM Atlas VR (model V-193) 8 8 N/A
Thoratec HMII PWM 7.2 — —M
BT listen-before-talking; MICSMedical Implant Communication Service; HMII Heartmate II;
WM  pulse-width modulator; SJM  St. Jude Medical.evices (LBT and operating frequency: 8 kHz), communication in
roximity of the Heartmate remained unavailable even if the initial
ecognition is performed far away from the LVAD pump. The
perating frequency of an ICD is thus not the only mechanism
hat explains the inability to interrogate the SJM ICDs in
roximity of the Heartmate II LVAD pump. Other potential
ources of interactions (such as the LBT frequency used) should be
aken into account before choosing a replacement device. In our
pinion, device interactions are important factors that should be
ecognized by manufacturers who are required to provide safety
nformation about this specific risk.
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eply
r. Le Poland de Waroux and colleagues have described an
nteraction of the Heartmate II left ventricular assist device
LVAD) (Thoratec Heartmate II, Thoratec, Pleasanton, Califor-
ia) and the St. Jude Medical (SJM) implantable cardioverter-
efibrillator (ICD) (Atlas II  HF, model V-367, St. Jude
edical, Sunnyvale, California) that is unique and not explained
y the previously published report from our group (1).
We commend Dr. Le Poland de Waroux and colleagues for
eciphering this new interaction; however, the nomenclature of the
nteraction is incorrect in their description. The interaction in
uestion is based upon the need for the device programmer to serve
oth older and newer generation devices.
The programmer (SJM-Merlin) utilizes an 8-kHz “test” pulse
f inductive telemetry (direct link to a programmer head) to
etermine whether a newer generation (64-kHz operating fre-
uency) or older generation (8-kHz operating frequency) is in
lace (A. Dianaty, written communication, May 2008). This test
r “handshake” pulse lasts 2 to 5 s, and it is the transient nature of
his pulse that explains the ability of shielding to overcome the
nteraction with the Atlas II (A. Dianaty, written communication,
ay 2008).
